261 related articles for article (PubMed ID: 29102309)
1. Challenges in culture-negative cases of Madurella mycetomatis: A case report re-accentuating PCR as an essential diagnostic tool.
K S; Das S; Pandhi D; Rai G; Ansari MA; Gupta C; Haque S; Dar SA
J Mycol Med; 2017 Dec; 27(4):577-581. PubMed ID: 29102309
[TBL] [Abstract][Full Text] [Related]
2. Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetoma.
de Hoog GS; Adelmann D; Ahmed AO; van Belkum A
Mycoses; 2004 Apr; 47(3-4):121-30. PubMed ID: 15078428
[TBL] [Abstract][Full Text] [Related]
3. Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.
Ahmed SA; van de Sande WW; Desnos-Ollivier M; Fahal AH; Mhmoud NA; de Hoog GS
J Clin Microbiol; 2015 Oct; 53(10):3280-5. PubMed ID: 26246484
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
Nyuykonge B; Klaassen CHW; Zandijk WHA; de Hoog GS; Ahmed SA; Desnos-Ollivier M; Verbon A; Bonifaz A; van de Sande WWJ
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1828-1834. PubMed ID: 32233084
[TBL] [Abstract][Full Text] [Related]
5. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan.
Ahmed A; Adelmann D; Fahal A; Verbrugh H; van Belkum A; de Hoog S
J Clin Microbiol; 2002 Mar; 40(3):1031-6. PubMed ID: 11880433
[TBL] [Abstract][Full Text] [Related]
6. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.
Ahmed A; van de Sande W; Verbrugh H; Fahal A; van Belkum A
J Clin Microbiol; 2003 Oct; 41(10):4537-41. PubMed ID: 14532179
[TBL] [Abstract][Full Text] [Related]
7. New species of Madurella, causative agents of black-grain mycetoma.
de Hoog GS; van Diepeningen AD; Mahgoub el-S; van de Sande WW
J Clin Microbiol; 2012 Mar; 50(3):988-94. PubMed ID: 22205798
[TBL] [Abstract][Full Text] [Related]
8. Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region.
Karrakchou B; Boubnane I; Senouci K; Hassam B
BMC Dermatol; 2020 Jan; 20(1):1. PubMed ID: 31918687
[TBL] [Abstract][Full Text] [Related]
9. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
Mekoguem C; Triboulet C; Gouveia A
J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of Madurella mycetomatis from two cases of black grain mycetoma in Libya.
Ellabib MS; Refaai A; Khalifa Z; Kavanagh K
Mycoses; 2003 Sep; 46(8):339-41. PubMed ID: 12950906
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma.
Yan J; Deng J; Zhou CJ; Zhong BY; Hao F
J Clin Microbiol; 2010 Jan; 48(1):251-7. PubMed ID: 19923486
[TBL] [Abstract][Full Text] [Related]
12. Madura foot (madurella mycetoma) presenting as a plantar fibroma: a case report.
Salamon ML; Lee JH; Pinney SJ
Foot Ankle Int; 2006 Mar; 27(3):212-5. PubMed ID: 16539905
[No Abstract] [Full Text] [Related]
13. VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
Lim W; Eadie K; Horst-Kreft D; Ahmed SA; Fahal AH; van de Sande WWJ
Med Mycol; 2019 Jun; 57(4):434-440. PubMed ID: 30085253
[TBL] [Abstract][Full Text] [Related]
14. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
[TBL] [Abstract][Full Text] [Related]
15. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
[TBL] [Abstract][Full Text] [Related]
16. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
[TBL] [Abstract][Full Text] [Related]
17. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
[TBL] [Abstract][Full Text] [Related]
18. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis.
Ahmed AO; Mukhtar MM; Kools-Sijmons M; Fahal AH; de Hoog S; van den Ende BG; Zijlstra EE; Verbrugh H; Abugroun ES; Elhassan AM; van Belkum A
J Clin Microbiol; 1999 Oct; 37(10):3175-8. PubMed ID: 10488173
[TBL] [Abstract][Full Text] [Related]
19. Madurella real-time PCR, a novel approach for eumycetoma diagnosis.
Arastehfar A; Lim W; Daneshnia F; van de Sande WWJ; Fahal AH; Desnos-Ollivier M; de Hoog GS; Boekhout T; Ahmed SA
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007845. PubMed ID: 31940343
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
